2563 — Beijing Biostar Pharmaceuticals Co Cashflow Statement
0.000.00%
Last trade - 00:00HealthcareHighly SpeculativeSmall Cap
- HK$1.61bn
- HK$1.61bn
- CNY66.64m
Annual cashflow statement for Beijing Biostar Pharmaceuticals Co, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.
2022 December 31st | 2023 December 31st | |
|---|---|---|
| Period Length: | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS |
| Standards: | HKAS | HKAS |
| Status: | Final | Final |
| Net Income/Starting Line | -161 | -190 |
| Depreciation | ||
| Amortisation | ||
| Non-Cash Items | 48.7 | 18.5 |
| Unusual Items | ||
| Other Non-Cash Items | ||
| Changes in Working Capital | 21.9 | 11.2 |
| Change in Accounts Receivable | ||
| Change in Inventories | ||
| Change in Prepaid Expenses | ||
| Change in Payable / Accrued Expenses | ||
| Change in Other Liabilities | ||
| Cash from Operating Activities | -79.4 | -149 |
| Capital Expenditures | -32.7 | -27.8 |
| Purchase of Fixed Assets | ||
| Purchase / Acquisition of Intangibles | ||
| Other Investing Cash Flow Items | -114 | 158 |
| Sale/Maturity of Investment | ||
| Purchase of Investments | ||
| Other Investing Cash Flow | ||
| Cash from Investing Activities | -147 | 130 |
| Financing Cash Flow Items | 4.66 | -0.125 |
| Other Financing Cash Flow | ||
| Net Issuance / Retirement of Debt | ||
| Cash from Financing Activities | 3.53 | -1.13 |
| Foreign Exchange Effects | ||
| Beginning Cash Balance | ||
| Ending Cash Balance | ||
| Net Change in Cash | -208 | -22 |